Primary Care Medicine: On Demand 6.2
|
$500.00
Use promo code (Limited Offer)
20 CREDITS
  Hurry! Offer expires June 30, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (42 minutes) | Angioedema – Or What To Do With Your Patient Who Swells | A. Baptist, MD |
| Session 2 (59 minutes) | Secondary Causes of Hypertension: An Update | J. Basile, MD |
| Session 3 (65 minutes) | I Don't Understand Why Laxatives are Failing? The Wrong Treatment for the Wrong Disorder | D. Brenner, MD |
| Session 4 (61 minutes) | Celiac Disease or Something Else? | P. Buch, MD |
| Session 5 (62 minutes) | Commonly Missed Orthopedic Injuries | D. Campagne, MD |
| Session 6 (61 minutes) | A True Clinic-based Approach to Dementia | G. Day, MD |
| Session 7 (61 minutes) | Headache: Finding the Wolf in Sheep's Clothing… and Treatment Pearls | A. Graham, MD |
| Session 8 (62 minutes) | Thyroid Disease in Women | J. Green, MD |
| Session 9 (62 minutes) | Update in Osteoporosis | J. Green, MD |
| Session 10 (62 minutes) | The New Definition of Heart Failure: Words Matter | A. Hicks, MD |
| Session 11 (32 minutes) | Bedside Procedures for the Acute Primary Care Practice (w/ live demonstrations | G. Higgins, MD |
| Session 12 (48 minutes) | Acute Care Topic Updates (Hypertension, Opioids and Febrile Seizures) | G. Higgins, MD |
| Session 13 (62 minutes) | Diabetes-on-a-Budget: Cost-Effective Approaches to Therapy | S. Inzucchi, MD |
| Session 14 (62 minutes) | SGLT2 Inhibitors: When to Use, When to Avoid? | S. Inzucchi, MD |
| Session 15 (63 minutes) | Cholesterol Update | H. Johnson, MD |
| Session 16 (48 minutes) | What Everyone Needs to Know About Antibiotic Allergies | D. Khan, MD |
| Session 17 (76 minutes) | Nonalcoholic Fatty Liver Disease (NAFLD): What Does the Primary Care Clinician Need to Know | B. Pearlman, MD |
| Session 18 (64 minutes) | Treating Common Psychiatric Disorders | K. Roussos-Ross, MD |
| Session 19 (43 minutes) | The Role of Lifestyle Interventions in the Treatment of Obesity: Implementing Practical Therapies into Clinical Practice | C. Still, DO |
| Session 20 (57 minutes) | Lipid Lowering Therapies from Statins and PCSK9 Inhibitors to the Newest Agents | P. Taub, MD |
| Session 21 (46 minutes) | The Patient with Autosomal Dominant Polycystic Kidney Disease (ADKPKD) | M. Weir, MD |
Program Overview
Presented by Continuing Education Company (CEC) for the past 30 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from recent conferences. The emphasis of this course is on practical and useful information for clinical practice.
This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate.
Faculty
Alan P. Baptist, MD, MPH
Associate Professor of Medicine
Division of Allergy & Clinical Immunology
Director, UM Asthma Program
University of Michigan Medical School
Ann Arbor, MI
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Irene D. Pritzker Foundation Research Scholar
Director, Northwestern Neurogastromotility and Integrated Bowel Dysfunction Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University Feinberg School of Medicine
Chicago, IL
Peter Buch, MD, FACG, AGAF, FACP
Associate Clinical Professor of Medicine, GI
University of Connecticut School of Medicine
University of New England College of Osteopathic Medicine
Frank H Netter School of Medicine/Quinnipiac University
Manchester, CT
Danielle D. Campagne, MD, FACEP
Vice Chair of Emergency Medicine, UCSF-Fresno
Associate Professor of Clinical Emergency Medicine
University of California San Francisco
Fresno, CA
Gregory S. Day, MD, MSc, MSCI, FAAN
Senior Associate Consultant
Dept. of Neurology
Assistant Professor of Neurology
Mayo Clinic College of Medicine and Science
Jacksonville, FL
Autumn C. Graham, MD
Associate Professor of Emergency Medicine
Eastern Virginia Medical School
Emergency Medicine Physician
Emergency Medicine of Tidewater
Norfolk, VA
Jennifer Green, MD
Professor of Medicine
Division of Endocrinology, Metabolism and Nutrition
Duke University Medical Center
Duke Clinical Research Institue
Durham, NC
Albert J. Hicks III, MD, MPH
Advanced Heart Failure and Transplant Cardiologist
University of Maryland
Baltimore, MD
George L. Higgins III, MD, FACEP
Emeritus Professor of Emergency Medicine
Maine Medical Center
Tufts University School of Medicine
Portland, ME
Emergency Partner
BlueWater Health
Brunswick, ME
Silvio E. Inzucchi, MD
Professor of Medicine, Endocrinology
Clinical Director, Section of Endocrinology
Director, Yale Diabetes Center
Director, Endocrinology & Metabolism Fellowship
Director, Yale Affiliated Hospitals
Yale School of Medicine
New Haven, CT
Heather M. Johnson, MD, MS, MMM, FAHA, FACC, FASPC
Preventive Cardiologist
Christine E. Lynn Women’s Health & Wellness Institute
Boca Raton Regional Hospital
Boca Raton, FL
David A. Khan, MD
Program Director, Allergy & Immunology Fellowship Program
Professor of Medicine and Pediatrics
UT Southwestern Medical Center
Dallas, TX
Brian Pearlman, MD, FACP, FAASLD, AAHIVS
Medical Director, Center for Hepatitis C, Wellstar Atlanta Medical Center
Professor of Medicine, Medical College of Georgia
Professor of Medicine, Emory School of Medicine
Atlanta, GA
Kay Roussos-Ross, MD
Associate Professor
Division Director Gynecology, Gynecologic Surgery, and Obstetrics
Department of Obstetrics and Gynecology
University of Florida College of Medicine
Gainesville, FL
Christopher D. Still, DO, FACN, FACP, FTOS
Director, Geisinger Obesity Institute
Medical Director, Center for Nutrition and Weight Management
Medical Director, Employee Wellness
Associate, Department of Gastroenterology and Nutrition
Geisinger Health Care System
Danville, PA
Pam R. Taub, MD, FACC, FAPSC
Associate Professor of Medicine
University of California San Diego School of Medicine
Founding Director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center
San Diego, CA
Matthew R. Weir, MD
Professor of Medicine
Director, Division of Nephrology
University of Maryland School of Medicine
Baltimore, MD
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company, Inc. designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST complete the activity and the evaluation form. For ABIM MOC points, your information will be shared with the ABIM through the ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 20 hours of participation for completing this activity, 10 of which can be used towards Pharmacology, for completing this activity.
Release Date: 8/24/2022
Expiration Date: 8/24/2025 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Ryan Townsend, CHCP - Reviewer (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Alan Baptist, MD | Research Grant: American Lung Association, AstraZeneca, Biocryst, Novartis, and Takeda Consultant: NIH |
| Jan Basile, MD | Research Grant: Ablative Solutions (Target BP 1) and ReCor (RADIANCE I and II) Consultant: Eli Lilly (SURPASS), Medtronic Adjudication Committee (AF-Hypertension Renal Denervation Study), and Up-to-Date (Hypertension Section) |
| Darren M. Brenner, MD | Consultant, Speakers Bureau: Alfasigma Pharmaceuticals, Redhill Biopharma, and Takeda Pharmaceuticals Advisory Board, Consultant, Speakers Bureau: Allergan Pharmaceuticals, Ironwood, and Salix Pharmaceuticals Consultant: Alnylam Pharmaceuticals Advisory Board, Consultant: Arena Pharmaceuticals |
| Peter Buch, MD | Nothing to Disclose |
| Danielle Campagne, MD | Employee: EM:RAP Royalties from book published: Oxford Press |
| Gregory Day, MD | Stockholder: ANI Pharmaceuticals Research Grant (paid to Mayo Clinic): Alzheimer’s Association, Chan-Zuckerberg Initiative, and NIH K23AG064029 Consultant: DynaMed (EBSCO Health) Consultant, Research Grant, Ownership Interest: Parabon Nanolabs, Inc. Clinical Trials (paid to Mayo Clinic): Sub-I on AD studies (Eli Lilly, Biogen, Roche) |
| Autumn Graham, MD | Nothing to Disclose |
| Jennifer Green, MD | Consultant: Astra Zeneca, Bayer, Hawthorne Effect/Omada, Novo Nordisk, Pfizer, and Sanofi Consultant, Research Grant: Boehringer Ingelheim Research Grant: Merck and Roche |
| Albert Hicks, III, MD | Speakers Bureau: Alnylam, Boehringer Ingelheim, and CareDx |
| George L. Higgins, MD | Nothing to Disclose |
| Silvio Inzucchi, MD | Consultant: Abbott, Experion Advisory Board, Clinical Trial Executive Committee, Consulting Fees, Lectures: Astra Zeneca Advisory Board, Clinical Trial Executive Committee, Lectures: Boehringer Ingelheim Advisory Board: Lexicon and vTv Therapeutics Consultant, Consulting Fees: Merck/Pfizer Advisory Board, Clinical Trial Steering Committee: Novo Nordisk |
| Heather Johnson, MD | Nothing to Disclose |
| David Khan, MD | Nothing to Disclose |
| Brian Pearlman, MD | Honoraria, Research Grant, Speakers Bureau: Abbvie Research Grant: Genfit and Novartis Advisory Board, Research Grant, Speakers Bureau: Gilead Sciences |
| Kay Roussos-Ross, MD | Nothing to Disclose |
| Christopher D. Still, DO | Consultant, Speakers Bureau: Novo Nordisk |
| Pam Taub, MD | Advisory Board, Consultant: Amarin, Amgen, Bayer, Boehringer Ingelheim, Esperion, Medtronic, Novo Nordisk, and Sanofi Grant Recipient: American Heart Association and FEMA Shareholder: Empirium Bio Research Grant: National Institute of Health (NIH) R01 |
| Matthew Weir, MD | Consultant: Akebia Therapeutics Advisory Board: Astra Zeneca, Bayer, Boehringer-Ingelheim, CareDX, Janssen, Merck, Novo Nordisk, and Vifor Pharma Grant Recipient: National Institute of Diabetes and Digestive Kidney (NIDDK): R01DK 066013, and U01DK106102 Research Grant: NHLBI: R01HL127422, R01HL132732, and U01DK116095 |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.